東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Patent Quality And Company Performan...

Vazquez Toro, Guillermo J.

Linked to FindBook

Google Book

Amazon

博客來

Patent Quality And Company Performance: A Sample within the USA Biotechnology and Pharmaceutical Industry.

Record Type:	Electronic resources : Monograph/item
Title/Author:	Patent Quality And Company Performance: A Sample within the USA Biotechnology and Pharmaceutical Industry./
Author:	Vazquez Toro, Guillermo J.
Description:	200 p.
Notes:	Source: Dissertation Abstracts International, Volume: 75-04(E), Section: A.
Contained By:	Dissertation Abstracts International75-04A(E).
Subject:	Economics, Finance. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3577982
ISBN:	9781303680052

Patent Quality And Company Performance: A Sample within the USA Biotechnology and Pharmaceutical Industry.
Vazquez Toro, Guillermo J.

Patent Quality And Company Performance: A Sample within the USA Biotechnology and Pharmaceutical Industry. - 200 p.

Source: Dissertation Abstracts International, Volume: 75-04(E), Section: A.

Thesis (Ph.D.)--Inter-American University of Puerto Rico (Puerto Rico), 2013.

This Dissertation investigates the relationship between patent quality and company performance for a sample from the US Biotechnology and Pharmaceutical Industry. The methodology devised comprehensively examines patent worth (patent's references), patent protection (claims and family patents) and patent quality (references, claims and family patents) to determine their implications on firm leverage (SE, TA), profits (ROE, ROA), and market value (B/M, MCap). The selected sample comprises 1,536 companies, and 285,000 patents from 1999 to 2009. The results show that total revenue just responds to changes in R&D intensity, and patenting intensity. A 10 percent increase in patent value results in a corresponding increase rate on the market capitalization index for the full sample and a 14 percent increase for the chemicals and allied products group (SIC 28). Increases (10%) in patent protection and quality present average increases of 15 percent on market capitalization for the full sample and 8 percent for the chemicals and allied products group (SIC 28). The medical devices group (SIC 38) results suggest that Mcap increases 10 percent by the same increase in patent value index. Patent protection and quality increases (10%) suggest an average 8 percent increase in Mcap. Results suggest that profits, leverage and market indices respond differently to 10 percent increases in patent value, patent protections and patent quality. The aforementioned effects suggest that the qualitative indexes follow company related market activities and business valuations for the chemical and allied products, and medical devices industrial sectors.

ISBN: 9781303680052Subjects--Topical Terms:

626650
Economics, Finance.

Patent Quality And Company Performance: A Sample within the USA Biotechnology and Pharmaceutical Industry.
LDR:02606nmm a2200289 4500 001 2055166
005 20141112080400.5
008 170521s2013 ||||||||||||||||| ||eng d
020 $a 9781303680052
035 $a (MiAaPQ)AAI3577982
035 $a AAI3577982
040 $a MiAaPQ $c MiAaPQ
100 1 $a Vazquez Toro, Guillermo J. $3 3168791
245 1 0 $a Patent Quality And Company Performance: A Sample within the USA Biotechnology and Pharmaceutical Industry.
300 $a 200 p.
500 $a Source: Dissertation Abstracts International, Volume: 75-04(E), Section: A.
500 $a Adviser: Ahmad H. Juma'h.
502 $a Thesis (Ph.D.)--Inter-American University of Puerto Rico (Puerto Rico), 2013.
520 $a This Dissertation investigates the relationship between patent quality and company performance for a sample from the US Biotechnology and Pharmaceutical Industry. The methodology devised comprehensively examines patent worth (patent's references), patent protection (claims and family patents) and patent quality (references, claims and family patents) to determine their implications on firm leverage (SE, TA), profits (ROE, ROA), and market value (B/M, MCap). The selected sample comprises 1,536 companies, and 285,000 patents from 1999 to 2009. The results show that total revenue just responds to changes in R&D intensity, and patenting intensity. A 10 percent increase in patent value results in a corresponding increase rate on the market capitalization index for the full sample and a 14 percent increase for the chemicals and allied products group (SIC 28). Increases (10%) in patent protection and quality present average increases of 15 percent on market capitalization for the full sample and 8 percent for the chemicals and allied products group (SIC 28). The medical devices group (SIC 38) results suggest that Mcap increases 10 percent by the same increase in patent value index. Patent protection and quality increases (10%) suggest an average 8 percent increase in Mcap. Results suggest that profits, leverage and market indices respond differently to 10 percent increases in patent value, patent protections and patent quality. The aforementioned effects suggest that the qualitative indexes follow company related market activities and business valuations for the chemical and allied products, and medical devices industrial sectors.
590 $a School code: 0955.
650 4 $a Economics, Finance. $3 626650
650 4 $a Patent Law. $3 1679968
650 4 $a Intellectual Property. $3 782112
690 $a 0508
690 $a 0562
690 $a 0513
710 2 $a Inter-American University of Puerto Rico (Puerto Rico). $3 3168792
773 0 $t Dissertation Abstracts International $g 75-04A(E).
790 $a 0955
791 $a Ph.D.
792 $a 2013
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3577982